Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series

Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series

Background: The management of cholangiocarcinoma is continually reviewed on a current evidence basis to develop practice guidelines and consensus statements. However, the standardized treatment guidelines are still unclear for cholangiocarcinoma patients who are listed for liver transplantation. We...

Full description

Bibliographic Details
Main Authors: Maen Abdelrahim, Hadeel Al-Rawi, Abdullah Esmail, Jiaqiong Xu, Godsfavour Umoru, Fahad Ibnshamsah, Ala Abudayyeh, David Victor, Ashish Saharia, Robert McMillan, Ebtesam Al Najjar, Doaa Bugazia, Maryam Al-Rawi, Rafik M. Ghobrial
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Current Oncology
Subjects:
hepatocellular carcinoma
gemcitabine
cisplatin
immunotherapy
liver transplantation
cholangiocarcinoma
Online Access:https://www.mdpi.com/1718-7729/29/5/290

Internet

https://www.mdpi.com/1718-7729/29/5/290

Similar Items